Drugs / Healive
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06058416 | Oct 2023 → Mar 2028 expected | hepatitis A virus infection | Sinovac Biotech Co., Ltd | Active not recruiting | No outcome recorded |
| Phase 4 | NCT01252680 | Apr 2010 → Feb 2011 | hepatitis A virus infection | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
| Phase 4 | NCT00534885 | Mar 2006 → Oct 2017 | hepatitis A virus infection | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Healive | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06058416 ↗ |
| Modality | Vaccine | “preservative-free inactivated hepatitis A vaccine” NCT00534885 ↗ |